IRIS
MEGNA, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 12.023
EU - Europa 9.013
NA - Nord America 6.957
SA - Sud America 1.716
AF - Africa 298
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 30.037
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.668
SG - Singapore 6.293
RU - Federazione Russa 4.386
CN - Cina 2.853
DE - Germania 1.810
BR - Brasile 1.429
IT - Italia 1.202
HK - Hong Kong 1.071
VN - Vietnam 666
IN - India 415
NL - Olanda 317
KR - Corea 266
GB - Regno Unito 216
FI - Finlandia 200
FR - Francia 193
IE - Irlanda 151
CA - Canada 123
AR - Argentina 120
MX - Messico 111
UA - Ucraina 99
CI - Costa d'Avorio 82
ZA - Sudafrica 80
BD - Bangladesh 73
SE - Svezia 73
PL - Polonia 72
ES - Italia 70
JP - Giappone 55
EC - Ecuador 54
AT - Austria 49
ID - Indonesia 47
TR - Turchia 45
IQ - Iraq 39
BG - Bulgaria 29
PK - Pakistan 29
CO - Colombia 27
MA - Marocco 26
LT - Lituania 24
PY - Paraguay 23
VE - Venezuela 20
KE - Kenya 17
CL - Cile 15
SA - Arabia Saudita 15
AU - Australia 14
PE - Perù 14
BE - Belgio 13
UZ - Uzbekistan 13
CZ - Repubblica Ceca 12
GR - Grecia 12
RO - Romania 12
TW - Taiwan 12
CH - Svizzera 11
EG - Egitto 11
TN - Tunisia 11
AE - Emirati Arabi Uniti 10
UY - Uruguay 10
DK - Danimarca 9
DZ - Algeria 9
IL - Israele 9
IR - Iran 9
JO - Giordania 9
OM - Oman 9
RS - Serbia 9
AZ - Azerbaigian 8
DO - Repubblica Dominicana 8
KZ - Kazakistan 8
PA - Panama 8
PH - Filippine 8
BB - Barbados 7
NP - Nepal 7
TH - Thailandia 7
MY - Malesia 6
AL - Albania 5
CR - Costa Rica 5
CY - Cipro 5
EE - Estonia 5
GT - Guatemala 5
KH - Cambogia 5
PT - Portogallo 5
SN - Senegal 5
AM - Armenia 4
CG - Congo 4
ET - Etiopia 4
EU - Europa 4
HR - Croazia 4
HU - Ungheria 4
LY - Libia 4
SC - Seychelles 4
BH - Bahrain 3
BO - Bolivia 3
BY - Bielorussia 3
GH - Ghana 3
GN - Guinea 3
JM - Giamaica 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
MK - Macedonia 3
MR - Mauritania 3
NC - Nuova Caledonia 3
NE - Niger 3
Totale 29.949
Salva come PNG Salva come JPEG
Città #
Singapore 3.059
Hefei 1.311
Moscow 1.132
Hong Kong 1.058
Ashburn 702
Chandler 687
Beijing 615
Santa Clara 589
Krefeld 387
Los Angeles 255
Seoul 255
Ho Chi Minh City 249
Amsterdam 243
Kochi 222
Naples 211
Napoli 188
Boston 173
Bad Bellingen 171
Millbury 167
Redondo Beach 158
Dallas 156
Lawrence 146
Buffalo 136
Des Moines 131
São Paulo 125
Hanoi 115
Munich 114
The Dalles 110
New York 101
Nanjing 85
Seattle 77
Helsinki 70
Milan 70
Wilmington 63
Mexico City 62
Rome 58
Princeton 57
Dublin 56
Houston 56
Brooklyn 54
Frankfurt am Main 54
Falkenstein 52
Tokyo 49
Rio de Janeiro 48
Warsaw 48
Chicago 45
Dong Ket 44
Turku 44
Düsseldorf 43
Fairfield 42
Montreal 42
London 40
Chennai 39
Boardman 38
Lappeenranta 38
Guangzhou 36
Nuremberg 35
Menlo Park 34
Orem 33
San Francisco 32
Stockholm 32
Poplar 31
Washington 31
Woodbridge 30
Denver 29
Johannesburg 29
Atlanta 28
Belo Horizonte 28
Nanchang 28
Kronberg 27
Sofia 27
Council Bluffs 25
Biên Hòa 24
Phoenix 24
Brasília 23
Curitiba 23
Arezzo 22
Ottawa 22
Da Nang 21
Pune 21
Campinas 20
Haiphong 20
Lauterbourg 20
Porto Alegre 20
Shenyang 20
Bengaluru 19
Toronto 19
Guayaquil 18
Shanghai 18
Tianjin 18
Ankara 17
Hebei 17
Manchester 17
Nairobi 17
Paris 17
Vienna 17
Buenos Aires 16
Mumbai 16
Quito 16
Salvador 16
Totale 15.393
Salva come PNG Salva come JPEG
Nome #
Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study 370
Multi-failure psoriasis patients: characterization of the patients and response to biological therapy in a multicenter Italian cohort 369
Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses – IL PSO (Italian landscape psoriasis) 352
Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study—IL PSO (ITALIAN LANDSCAPE PSORIASIS) 348
A case of aquagenic wrinkling of the palms 227
Very low-calorie ketogenic diet (VLCKD) in patients with psoriasis and obesity: an update for dermatologists and nutritionists 158
A case of the co-existence of subcorneal pustular dermatosis and pyoderma gangrenosum and a review of the literature 156
An indolent nasal form of primary cutaneous CD8-positive peripheral T-cell lymphoma not otherwise specified successfully treated with local radiation therapy- a new subtype? 151
Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications 148
Therapeutic update of biologics and small molecules for scalp psoriasis: a systematic review 145
Psoriasis and sport: a new ally? 142
Guselkumab, Risankizumab, and Tildrakizumab in the Management of Psoriasis: A Review of the Real-World Evidence 141
"Active" photoprotection: sunscreens with DNA repair enzymes. A review of the literature 137
Generalized Pustular Psoriasis rapidly and successfully treated with Ixekizumab in a Caucasian patient 133
The effect of the ketogenic diet on Acne: Could it be a therapeutic tool? 131
Efficacy and safety of risankizumab in psoriasis patients who failed anti‐IL‐17, anti‐12/23 and/or anti IL‐23: preliminary data of a real‐life 16‐week retrospective study 126
Generalized violaceous maculopapular rash and multiple verrucous nodules on the testes: a case of secondary syphilis misdiagnosed as lymphoma 124
What's new about atopic dermatitis and sporting activity 123
Vitamin D and its role in psoriasis: An overview of the dermatologist and nutritionist 119
Psoriasis Features in Patients with Inflammatory Bowel Disease 118
Possible role of BMP-4 in the hyper-pigmentation of psoriatic plaques after anti-TNF-α treatment 117
Persistent candidiasis infection during anti‐ IL ‐17 treatment for plaque psoriasis requiring biologic discontinuation: a case series and literature review 115
Apremilast efficacy and safety in elderly psoriasis patients over a 48-weeks period 115
Adult atopic dermatitis: a review 114
Cutaneous leucocytoclastic vasculitis during secukinumab treatment 114
Infantile Acute Generalized Pustular Psoriasis: A Case Report 113
QuantiFERON TB‐gold conversion rate among psoriasis patients under biologics: a 9‐year retrospective study 113
Efficacy and Safety of Anti-TNF Biosimilars for Psoriasis in Pediatric and Geriatric Populations: A 72-Week Real-Life Study 112
Systemic treatment for psoriasis and malignancies: A real risk? 112
Tattooing and hidradenitis suppurativa: stigmatization and camouflage 111
The Role of Thermal Water in Chronic Skin Diseases Management: A Review of the Literature 111
Photodynamic Therapy and Skin Appendage Disorders: A Review 110
A case of psoriatic alopecia secondary to certolizumab pegol: clinical and trichoscopic evaluation 110
L'avvento degli inibitori delle proteasi nella terapia dell'infezione da epatite C: Reazioni avverse dermatologiche 109
Calcipotriol/betamethasone dipropionate formulations for psoriasis: an overview of the options and efficacy data 109
Erythrodermic psoriasis successfully and rapidly treated with brodalumab: report of two cases 109
Chronic inducible urticarias in children 108
Biologics for psoriasis patients in the COVID-19 era: more evidence, less fears 108
Ciprofloxacin-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) in a psoriasis patient 108
A case of severe psoriatic arthritis with hands flexion contracture and palmar psoriasis successfully treated with guselkumab 107
Drug safety evaluation of tildrakizumab for psoriasis: a review of the current knowledge 107
Appearances may be deceiving 107
Psoriasis in a cohort of patients with common variable immunodeficiency 107
Cutaneus sarcoidosis small-fiber neuropathy resembling leprosy: a case report 107
Is there any association between psoriasis, psoriatic arthritis and thyroid autoimmunity? 107
Hidradenitis suppurativa: guidelines of the Italian Society of Dermatology and Venereology (SIDeMaST) for the use of anti-TNF-α agents. 106
Skin diseases and visual arts 105
Pyoderma gangrenosum successfully treated with topical tacrolimus 105
Hypersensitivity reaction to certolizumab pegol in a patient affected by psoriatic arthritis 105
Eczematous eruption after brodalumab successfully treated with guselkumab and dupilumab 104
A case of linear psoriasis in a young patient with Down syndrome and review of the literature 104
Corrigendum: A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab (Clin Cosmet Investig Dermatol. (2023), 16, (3503–3507), 10.2147/CCID.S447123) 104
Chronic hand Eczema: Is IL-36á helpful in diagnosis and classification? 104
Neutrophilic dermatosis in pregnancy: An uncommon course 104
Immunocytometric analysis of COVID patients: A contribution to personalized therapy? 104
Risk Factors for Psoriasis Flares: A Narrative Review 103
The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review 103
Psoriatic arthritis and psoriasis: differential diagnosis 103
Intralesional Methotrexate for the Treatment of Keratoacanthoma: The Neapolitan Experience 103
Erythrodermic Pityriasis Rubra Pilaris treatment: two case reports and literature review 103
Teledermatology for acne during COVID-19: high patients' satisfaction in spite of the emergency 103
Eczematous drug eruption in patients with psoriasis under anti‐interleukin‐17A: does interleukin‐22 play a key role? 103
Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part II: focus on elderly patients 102
Efficacy and safety of ixekizumab in a group of 16 elderly patients with psoriasis over a 1‐year period 102
Psoriatic Alopecia and Paradoxical Psoriasis Induced by Adalimumab Successfully Treated with Certolizumab: Clinical, Trichoscopic, and in vivo Reflectance Confocal Microscopy Features 101
The impact of COVID ‐19 infection on psoriatic patients treated with biologics: an Italian experience 101
Psoriasis in elderly and non elderly population: clinical and molecular features. 101
Biologic Therapies, Psoriasis, and COVID-19: Our Experience at the Psoriasis Unit of the University of Naples Federico II 101
Effectiveness of Brodalumab in Patients with Moderate-to-Severe Plaque Psoriasis Located in Difficult-to-Treat Areas 100
Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part I: focus on pediatric patients 100
Anterior Cervical Hypertrichosis: A Case Report and Review of the Literature. 100
Dermoscopic patterns of intradermal naevi 100
A multidisciplinary care unit approach for the management of psoriatic arthritis: an Italian experience 99
Desmosomes in heart and skin: friends or foes? 99
Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience 99
Efficacy and Safety of Tildrakizumab in a Patient with Chronic HBV Infection 99
Bimekizumab for the Treatment of Plaque Psoriasis With Involvement of Genitalia: A 16-Week Multicenter Real-World Experience - IL PSO (Italian Landscape Psoriasis) 99
A case of Stewart-Treves Syndrome of the lower limbs: The usefulness of dermoscopy 99
16-year real-life study on the prevalence of mycoses in a paediatric population 99
Irisin, a novel metabolic biomarker in hidradenitis suppurativa: correlation with clinical responsivity to anti-TNF-α therapy 98
Insulin Resistance and Skin Diseases 98
Giant nodular melanoma of the nose in a 78‐year old female refusing complete excision 98
Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for Psoriasis 97
Management of Psoriasis Patients with Serious Infectious Diseases 97
Long-Term Efficacy of Vismodegib After its Withdrawal and Patients’ Health-Related Quality of Life Using the Dermatology Life Quality Index (DLQI) 97
Garbage and skin diseases related risk. 97
Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world study 97
Ixekizumab: an efficacious treatment for both psoriasis and hidradenitis suppurativa 97
Generalized versus localized vitiligo after ixekizumab: May previous treatment affect the clinical presentation? 96
Hidradenitis Suppurativa and JAK Inhibitors: A Review of the Published Literature 96
The use of ChatGPT in the dermatological field: a narrative review 96
A case of Paediatric Acrodermatitis Continua of Hallopeau successfully treated with adalimumab biosimilar 96
Effectiveness and Safety of Deucravacitinib for the Management of Psoriasis: A Review of the Current Literature 95
Tildrakizumab for the treatment of moderate to severe psoriasis: results from a single center preliminary real‐life study 95
Adalimumab Biosimilar Efficacy and Safety in a 5-Year-Old Patient with Severe Plaque Psoriasis During SARS-CoV-2 Pandemic Outbreak 95
Efficacy of JAK inhibitors in the treatment of psoriasiform atopic dermatitis 95
Psoriasis and high school students: an educational approach 95
Patients' demographic and socioeconomic characteristics influence the therapeutic decision-making process in psoriasis 95
Melanocytic nevi in children of southern Italy: dermoscopic, constitutional, and environmental factors. 94
Aquagenic wrinkling of the palms: a case report and literature review 94
Totale 11.963
Salva come PNG Salva come JPEG
Categoria #
all - tutte 100.044
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.044
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021442 0 0 0 0 0 30 28 161 94 27 43 59
2021/20221.296 22 32 21 44 39 52 30 92 153 103 219 489
2022/20232.026 233 168 66 93 211 201 72 207 311 254 165 45
2023/20243.131 101 238 225 143 111 213 58 187 1.287 73 343 152
2024/202510.523 467 587 81 85 266 587 977 769 801 1.376 3.642 885
2025/202612.249 2.168 2.267 2.186 2.029 3.061 538 0 0 0 0 0 0
Totale 30.674